Antibody Drug Conjugates

Product

Information

Syngene's Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.
Main Categories
Innovative APIs
All Categories
Antibodies
Syngene International Ltd.Syngene, a leading global CRDMO with over 30 years of experience in solving complex R&D challenges, delivers integrated drug discovery, development, and manufacturing services across small and large molecules, including niche modalities such as ADCs, peptides, and oligonucleotides.Visitors will experience Syngene's elite-level client-centricity, robust supply chain, and scientific excellence at scale. From discovery to commercial manufacturing, Syngene partners with global pharma and biotech leaders to shape the future of science. Book a meeting with syngeneintl.com/cphi-frankfur...

Log in

See all the content and easy-to-use features by logging in or registering!